Navigation Links
Rochester Medical Reports Second Quarter Results
Date:5/5/2011

n the Company's strategic investment in Sales and Marketing. In the second quarter the completed expansion of the U.S. sales and marketing force added over a million dollars in incremental costs compared to the same period last year.  The Company believes the investment will generate significant increases in revenue over the next few years.

Commenting on today's results Rochester Medical's CEO and President Anthony J. Conway said, "The excellent 37% constant currency growth in Direct Sales for the quarter was in large part due to the Laprolan acquisition reinforced by continued solid growth in Direct Sales of 24% in the combined U.S. and U.K. markets where we have a sales force presence.  The growth was partially offset by a decline in Direct Sales in other parts of the world due to timing of orders and shipments.

"I want to thank our Laprolan employees for their spirit of co-operation and excitement as they have become an important part of the Rochester Medical Team.  Now, with significant presence in the U.K., The Netherlands, and the United States, and with sales in countries throughout the world, we are truly becoming a recognized global leader in our field."

Conway concluded, "By fiscal year end we expect to be operating profitably. Looking ahead, we are strongly focused on growing the top line, flattening costs, and generating profits."

Acquisition of Laprolan B.V.On April 7, 2011, Rochester Medical announced the completed acquisition of Laprolan B.V., the former Medical Supplies Division and wholly owned subsidiary of Fornix BioSciences N.V. Under the terms of the purchase agreement the purchase is deemed retroactive to January 1, 2011. The final purchase price for Laprolan B.V., was $14,878,125 net of interest paid.

Agreement with Teleflex IncorporatedRochester Medical today announced an exclusive agreement with Teleflex Incorporated whereby they will market and sell Rochester Medical's Strata-NF Anti-
'/>"/>

SOURCE Rochester Medical Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Rochester Medical Announces Second Quarter 2011 Earnings Conference Call Thursday, May 5, 2011
2. Rochester Medical Completes Acquisition of Laprolan
3. Fornix Shareholders Approve the Sale of Laprolan B.V. to Rochester Medical Corporation
4. Rochester Medical Reports First Quarter Results and Recent Developments
5. Rochester Medical Announces First Quarter 2011 Earnings Conference Call Tuesday, January 25, 2011
6. Rochester Medical Corporation Announces Agreement to Acquire Laprolan B.V.
7. Rochester Medical Reports Fourth Quarter and Year-End Results
8. Rochester Medical Announces Fourth Quarter 2010 Earnings Conference Call Thursday, November 4, 2010
9. AstraZeneca Joins Rochester Initiative to Further Cardiac Safety
10. Rochester Medical Corporation Honored by Premier Healthcare Alliance for Exceptional Supplier Performance
11. Rochester Medical Announces First Quarter 2010 Earnings Conference Call Tuesday, January 26, 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/19/2014)... , Deutschland, October 19, 2014 ... gefragt. Das Problem dabei ist, dass ... mit der Kompetenz zu teilen. Es ... deshalb freuen wir uns umso mehr, dass es ... ihre Gepflogenheiten bei Kühlketten aufzuschreiben - mit einem ...
(Date:10/17/2014)... 2014 With the recent changes in ... come across several challenges in creating and utilizing ... The Medical Affairs Consortium ... providing benchmarking and best practices across critical Medical ... service composed of three stages: 1) member-driven topic ...
(Date:10/17/2014)... -- Hanger, Inc. (NYSE: HGR ) announced today ... for the quarter ended September 30, 2014, on Thursday, ... call to discuss these results is scheduled to begin ... Those wishing to participate should call 1-877-662-6095. A replay ... dialing 1-855-859-2056 and referencing Conference ID # 91880739. ...
Breaking Medicine Technology:Vergleichsbericht zu Pharma-Kühlketten und CRT 2Early Key Findings from the Medical Affairs Consortium Research 2
... Antibacterial Products aimed at reducing cross contamination ... infections ... Corporation,announced today the SILVER SEAL(TM) family of antibacterial products for,infection ... and Mouse. According to the company, the,SILVER SEAL(TM) Keyboard and ...
... - Once Granted by the European Commission, ATRIPLA Would Represent the, First ... ... Union -, PRINCETON, N.J., FOSTER CITY, Calif. and WHITEHOUSE STATION, N.J., ... GILD ) and Merck & Co., Inc. (NYSE: MRK ),announced ...
Cached Medicine Technology:Seal Shield Launches World's First Antibacterial, Dishwasher Safe Keyboard and Mouse for Infection Control 2Seal Shield Launches World's First Antibacterial, Dishwasher Safe Keyboard and Mouse for Infection Control 3European CHMP Issues Positive Opinion for ATRIPLA(R) (efavirenz 600 mg/ emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) 2European CHMP Issues Positive Opinion for ATRIPLA(R) (efavirenz 600 mg/ emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) 3European CHMP Issues Positive Opinion for ATRIPLA(R) (efavirenz 600 mg/ emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) 4European CHMP Issues Positive Opinion for ATRIPLA(R) (efavirenz 600 mg/ emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) 5European CHMP Issues Positive Opinion for ATRIPLA(R) (efavirenz 600 mg/ emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) 6European CHMP Issues Positive Opinion for ATRIPLA(R) (efavirenz 600 mg/ emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) 7European CHMP Issues Positive Opinion for ATRIPLA(R) (efavirenz 600 mg/ emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) 8European CHMP Issues Positive Opinion for ATRIPLA(R) (efavirenz 600 mg/ emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) 9European CHMP Issues Positive Opinion for ATRIPLA(R) (efavirenz 600 mg/ emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) 10
(Date:10/19/2014)... The leading review website, Top10BestSEOHosting.com, ... and GreenGeeks are the best Dedicated Server Hosting ... who want to buy high quality hosting and ... IT manager of Top10BestSEOHosting.com says, “We believe that ... for everyone. A lot of the global clients ...
(Date:10/19/2014)... Texas (PRWEB) October 20, 2014 ... development for Partial Seizure, complete with comparative analysis ... mechanism of action (MoA), route of administration (RoA) ... featured news and press releases. It also reviews ... Partial Seizure and special features on late-stage and ...
(Date:10/19/2014)... Fancyflyingfox.com, an innovative company that provides many kinds of ... of 2014 mother of the bride dresses . ... with big discounts, up to 70% off. All consumers ... this special offer. , Owing to the company’s ... of the leading brands in the global market. A ...
(Date:10/19/2014)... October 20, 2014 Stephen T. Greenberg, M.D., ... nominated for the 10th consecutive year as one of Long ... Greenberg was also been nominated as the best provider for ... nominated as best Day Spa and best Laser Treatment center ... 14th and readers can vote for the contest once per ...
(Date:10/19/2014)... 20, 2014 – The U.S. Government has initiated ... Alzheimer,s disease by 2025. However, a workgroup of ... research milestones in the U.S. Government,s National Plan ... scope, increased in scale, and adequately funded in ... of proposals by the workgroup to enlarge and ...
Breaking Medicine News(10 mins):Health News:Top10BestSEOHosting.com Considers iPage And GreenGeeks As The Best Dedicated Server Hosting Suppliers 2Health News:Partial Seizure Therapeutic Pipeline Market Review H2 2014 in a New Report Available at RnRMarketResearch.com 2Health News:Partial Seizure Therapeutic Pipeline Market Review H2 2014 in a New Report Available at RnRMarketResearch.com 3Health News:Partial Seizure Therapeutic Pipeline Market Review H2 2014 in a New Report Available at RnRMarketResearch.com 4Health News:Fancyflyingfox.com Updates Its Website With New Mother Of The Bride Dresses For 2014 2Health News:Dr. Stephen T. Greenberg – Nominated for the 10th Consecutive Year for One of Long Island’s Best Cosmetic Surgeons for 2015 by the Long Island Press 2Health News:Scientists say national Alzheimer's plan milestones must be strengthened to meet goal by 2025 2Health News:Scientists say national Alzheimer's plan milestones must be strengthened to meet goal by 2025 3Health News:Scientists say national Alzheimer's plan milestones must be strengthened to meet goal by 2025 4Health News:Scientists say national Alzheimer's plan milestones must be strengthened to meet goal by 2025 5Health News:Scientists say national Alzheimer's plan milestones must be strengthened to meet goal by 2025 6
... executives took their cholesterol lowering medication as prescribed by ... the executives who took their medication even sporadically were ... study finding also questions the prevailing wisdom that income ... University of Michigan researchers studied 1,607 executive level managers ...
... who join a sorority* are more likely to judge ... self-objectification) and display higher levels of bulimic attitudes and ... the sorority,s recruitment process. Over time, those women who ... shame. These findings, part of Ashley Marie Rolnik,s senior ...
... lose weight or exercise, study finds , TUESDAY, March ... developing diabetes apparently isn,t enough to make most people take ... April issue of the American Journal of Preventive Medicine ... said they had tried to drop pounds or boost their ...
... This is Part ... RN Employment Lifecycle: Engagement, Retention and High-performance, , ... CHARLOTTE, NC (Vocus) March 2, 2010 -- Morehead, the human capital ... The free hour-long webinar will be broadcast on Tuesday, March 23, 2010 at 1:00 p.m. ...
... , ... ... ... ...
... ... ... ... ...
Cached Medicine News:Health News:Even the boss doesn't follow the doctor's orders 2Health News:Only the beautiful need apply 2Health News:Having Prediabetes May Not Kick-Start Prevention Efforts 2Health News:Morehead Presents Webinar on "When Satisfaction Isn't Enough: Improving RN Engagement" 2Health News:Morehead Presents Webinar on "When Satisfaction Isn't Enough: Improving RN Engagement" 3Health News:Yongye International to Present at Rodman & Renshaw Annual China Investment Conference 2Health News:Yongye International to Present at Rodman & Renshaw Annual China Investment Conference 3Health News:Yongye International to Present at Rodman & Renshaw Annual China Investment Conference 4Health News:Yongye International to Present at Rodman & Renshaw Annual China Investment Conference 5Health News:Yongye International to Present at Rodman & Renshaw Annual China Investment Conference 6Health News:Yongye International to Present at Rodman & Renshaw Annual China Investment Conference 7Health News:Yongye International to Present at Rodman & Renshaw Annual China Investment Conference 8Health News:Yongye International to Present at Rodman & Renshaw Annual China Investment Conference 9Health News:Twenty-Five Years of HIV Blood Testing Helped to Positively Transform Global Health Crisis 2Health News:Twenty-Five Years of HIV Blood Testing Helped to Positively Transform Global Health Crisis 3Health News:Twenty-Five Years of HIV Blood Testing Helped to Positively Transform Global Health Crisis 4Health News:Twenty-Five Years of HIV Blood Testing Helped to Positively Transform Global Health Crisis 5Health News:Twenty-Five Years of HIV Blood Testing Helped to Positively Transform Global Health Crisis 6Health News:Twenty-Five Years of HIV Blood Testing Helped to Positively Transform Global Health Crisis 7Health News:Twenty-Five Years of HIV Blood Testing Helped to Positively Transform Global Health Crisis 8Health News:Twenty-Five Years of HIV Blood Testing Helped to Positively Transform Global Health Crisis 9Health News:Twenty-Five Years of HIV Blood Testing Helped to Positively Transform Global Health Crisis 10Health News:Twenty-Five Years of HIV Blood Testing Helped to Positively Transform Global Health Crisis 11Health News:Twenty-Five Years of HIV Blood Testing Helped to Positively Transform Global Health Crisis 12
Selute Picotip Atrial-J steroid eluting passive fixation lead...
The VascoTip J 9/60 PU is a unipolar tined, J-preformed permanent pacing lead. Due to advanced technology, VascoTip J 9/60 PU M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm),...
VascoTip is a unipolar tined permanent pacing lead. Due to advanced technology, VascoTip 9/60 M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm), 5 mm, 6 mm....
VascoTip is a unipolar tined permanent pacing lead. Due to advanced technology, VascoTip 9/60 M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm), 5 mm, 6 mm....
Medicine Products: